title: Bridging therapy in acute ischemic stroke: are we ready for a new standard of care?
authors.forename: Mikael
authors.initials: M
authors.lastname: Mazighi
authors.forename: Julien
authors.initials: J
authors.lastname: Labreuche
mesh_terms: D000208:Acute Disease; D002545:Brain Ischemia / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods / Q000592:standards / Q000639:trends*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods / Q000592:standards / Q000639:trends*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator